Author

Daniel E. Foxler

Observed names: D E Foxler, D. Foxler, Daniel E Foxler, Daniel Foxler

Observed institutions: University of Nottingham, Queen Mary University of London, Queen's Medical Centre, Barts Cancer Institute

ORCID: 0000-0003-3753-0278

Observed ORCID: 0000-0003-3753-0278

OpenAlex ID: A5026357606

The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity

2012 · Daniel E. Foxler, Katherine S. Bridge, et al. · Nature Cell Biology · 99

LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing

2010 · Victoria James, Yining Zhang, et al. · Proceedings of the National Academy of Sciences · 68

Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins

2017 · Katherine S. Bridge, Kunal M. Shah, et al. · Cell Reports · 67

The chromosome 3p21.3-encoded gene, LIMD1 , is a critical tumor suppressor involved in human lung cancer development

2008 · Tyson V. Sharp, Ahmad Al-Attar, et al. · Proceedings of the National Academy of Sciences · 66

A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia

2018 · Daniel E Foxler, Katherine S Bridge, et al. · EMBO Molecular Medicine · 34

Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition

2016 · M Dermit, P Casado, et al. · Oncogene · 32

LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death

2017 · Ling Wang, Mary E.A. Howell, et al. · Oncotarget · 21

Human feeder cell line for derivation and culture of hESc/hiPSc

2011 · Tristan R. McKay, Maria V. Camarasa, et al. · Stem Cell Research · 20

PU.1 is a major transcriptional activator of the tumour suppressor geneLIMD1

2011 · Daniel E. Foxler, Victoria James, et al. · FEBS Letters · 13

Vδ1+ T Cells: Adoptive Cell Therapy for the Treatment of Haematological Malignancies in Allogeneic Settings

2019 · André Simoes, Joanna Kawalkowska, et al. · Blood · 1

Abstract 4254: ADT-010, a novel immunomodulatory antibody that harnesses the anti-tumor properties of tissue-resident Vδ1 γδ T cells

2022 · Jose Munoz-Olaya, Aoife McGinley, et al. · Cancer Research

Abstract A31: Targeting APC loss using synthetic lethality in Colorectal Cancer

2017 · Hannah Shailes, Gemma Bridge, et al. · Molecular Cancer Therapeutics

Loss of LIM-domain proteins LIMD1, Ajuba and WTIP as a novel molecular mechanism for disease aetiology in clear cell renal cell carcinoma (ccRCC)

2016 · K. Smith, M. Sheaff, et al. · European Journal of Cancer

Genetic and functional characterisation of the LIMD1 promoter and gene product : from lung cancer to the hypoxic response

2012 · Daniel E. Foxler · Nottingham ePrints (University of Nottingham)

Works count: 14

Citation count: 421

H-index: 9

I10-index: 9